Market Research Logo

Pediatric Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Pediatric Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global pediatric vaccines market provides qualitative and quantitative analysis for the period of 2018 to 2024. The report predicts the global pediatric vaccines market to grow with a CAGR of 11.2% over the forecast period of 2016-2024. The study on pediatric vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2018 to 2024.
The report on pediatric vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pediatric vaccines market over the period of 2018 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pediatric vaccines market over the period of 2018 to 2024. Further, IGR- Growth Matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Growing Incidence of Chronic Disease
• Rising Awareness about the Importance of Early Vaccination
• Rising Funding of Government and Non-Government Agencies into the Pediatric Vaccination
2) Restraints
• Lack of Medical Services across developing countries
3) Opportunities
• Ongoing Research and Development to Produce the Novel Vaccines
• Growing Awareness about the Immunization
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global pediatric vaccines market is segmented on the basis of vaccine type, technology, application, and end user.

Global Pediatric Vaccines Market by Vaccine Type
• Monovalent
• Multivalent
Global Pediatric Vaccines Market by Technology
• Attenuated Live Viruses
• Inactivated Viruses
• Recombinant
• Subunits
• Toxoids
• Conjugates
• Polysaccharides
Global Pediatric Vaccines Market by Application
• Infectious Disease
• Allergy
• Cancer
Global Pediatric Vaccines Market by End User
• Hospitals
• Pediatric Clinics
• Research Organizations
• Others

Company Profiles
• Merck Sharp & Dohme Corp
• SANOFI
• Indian Immunologicals Limited
• Mitsubishi Tanabe Pharma Corporation
• Sinovac Biotech Ltd.
• GlaxoSmithKline plc
• Serum Institute of India Pvt. Ltd.
• Eli Lilly Company
• Pfizer, Inc.
• Bio Med Pvt. Ltd.

What does this report deliver?
1. Comprehensive analysis of global as well as regional markets of pediatric vaccines market.
2. Complete coverage of all the segments in pediatric vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global pediatric vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on pediatric vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pediatric vaccines market over the period of 2018 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Pediatric Vaccines Market Highlights
2.2. Pediatric Vaccines Market Projection
2.3. Pediatric Vaccines Market Regional Highlights
3. Global Pediatric Vaccines Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Vaccine Type
3.4.2. IGR-Growth Matrix Analysis by Technology
3.4.3. IGR-Growth Matrix Analysis by Application
3.4.4. IGR-Growth Matrix Analysis by End User
3.4.5. IGR-Growth Matrix Analysis by Region
3.5. Value chain Pediatric Vaccines Market
4. Pediatric Vaccines Market Macro Indicator Analysis
5. Global Pediatric Vaccines Market by Vaccine Type
5.1. Monovalent
5.2. Multivalent
6. Global Pediatric Vaccines Market by Technology
6.1. Attenuated Live Viruses
6.2. Inactivated Viruses
6.3. Recombinant
6.4. Subunits
6.5. Toxoids
6.6. Conjugates
6.7. Polysaccharides
7. Global Pediatric Vaccines Market by Application
7.1. Infectious Disease
7.2. Allergy
7.3. Cancer
8. Global Pediatric Vaccines Market by End User
8.1. Hospitals
8.2. Pediatric Clinics
8.3. Research Organizations
8.4. Others
9. Global Pediatric Vaccines Market by Region 2016-2024
9.1. North America
9.1.1. North America Pediatric Vaccines Market by Vaccine Type
9.1.2. North America Pediatric Vaccines Market by Technology
9.1.3. North America Pediatric Vaccines Market by Application
9.1.4. North America Pediatric Vaccines Market by End User
9.1.5. North America Pediatric Vaccines Market by Country
9.2. Europe
9.2.1. Europe Pediatric Vaccines Market by Vaccine Type
9.2.2. Europe Pediatric Vaccines Market by Technology
9.2.3. Europe Pediatric Vaccines Market by Application
9.2.4. Europe Pediatric Vaccines Market by End User
9.2.5. Europe Pediatric Vaccines Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Pediatric Vaccines Market by Vaccine Type
9.3.2. Asia-Pacific Pediatric Vaccines Market by Technology
9.3.3. Asia-Pacific Pediatric Vaccines Market by Application
9.3.4. Asia-Pacific Pediatric Vaccines Market by End User
9.3.5. Asia-Pacific Pediatric Vaccines Market by Country
9.4. RoW
9.4.1. RoW Pediatric Vaccines Market by Vaccine Type
9.4.2. RoW Pediatric Vaccines Market by Technology
9.4.3. RoW Pediatric Vaccines Market by Application
9.4.4. RoW Pediatric Vaccines Market by End User
9.4.5. RoW Pediatric Vaccines Market by Sub-region
10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Pediatric Vaccines Market
10.2. Companies Profiles
10.2.1. Merck Sharp & Dohme Corp
10.2.1.1. Overview
10.2.1.2. Company Snapshot
10.2.1.3. Financial Snapshot
10.2.1.4. Product portfolio
10.2.1.5. Recent developments
10.2.2. Sanofi
10.2.2.1. Overview
10.2.2.2. Company Snapshot
10.2.2.3. Financial Snapshot
10.2.2.4. Product portfolio
10.2.2.5. Recent developments
10.2.3. Indian Immunologicals Limited
10.2.3.1. Overview
10.2.3.2. Company Snapshot
10.2.3.3. Financial Snapshot
10.2.3.4. Product portfolio
10.2.3.5. Recent developments
10.2.4. Mitsubishi Tanabe Pharma Corporation
10.2.4.1. Overview
10.2.4.2. Company Snapshot
10.2.4.3. Financial Snapshot
10.2.4.4. Product portfolio
10.2.4.5. Recent developments
10.2.5. Sinovac Biotech Ltd.
10.2.5.1. Overview
10.2.5.2. Company Snapshot
10.2.5.3. Financial Snapshot
10.2.5.4. Product portfolio
10.2.5.5. Recent developments
10.2.6. Glaxosmithkline Plc
10.2.6.1. Overview
10.2.6.2. Company Snapshot
10.2.6.3. Financial Snapshot
10.2.6.4. Product portfolio
10.2.6.5. Recent developments
10.2.7. Serum Institute of India Pvt. Ltd.
10.2.7.1. Overview
10.2.7.2. Company Snapshot
10.2.7.3. Financial Snapshot
10.2.7.4. Product portfolio
10.2.7.5. Recent developments
10.2.8. Eli Lilly Company
10.2.8.1. Overview
10.2.8.2. Company Snapshot
10.2.8.3. Financial Snapshot
10.2.8.4. Product portfolio
10.2.8.5. Recent developments
10.2.9. Pfizer, Inc.
10.2.9.1. Overview
10.2.9.2. Company Snapshot
10.2.9.3. Financial Snapshot
10.2.9.4. Product portfolio
10.2.9.5. Recent developments
10.2.10. Bio Med Pvt. Ltd.
10.2.10.1. Overview
10.2.10.2. Company Snapshot
10.2.10.3. Financial Snapshot
10.2.10.4. Product portfolio
10.2.10.5. Recent developments
11. Appendix
11.1. Primary research findings and questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report